Aurobindo Pharma Q4 Results
- BSE: 524804
- NSE: AUROPHARMA
- ISIN: INE406A01037
- Sector: Major Drugs
BSE
1,236.35
12.70 (1.04%)
12.70 (1.04%)Volume10.45 K
Updated: Mon 25 Nov, 2024 | 15:29:42
NSE
1,241.7518.05 (1.48%)
18.05 (1.48%)Volume1.76 M
Updated: Mon 25 Nov, 2024 | 15:31:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Aurobindo Pharma Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 7,580.15 | 6,407.13 | -% | 6,472.96 | -% |
| Selling/ General/ Admin Expenses Total | 1,026.32 | 921.72 | -% | 851.90 | -% |
| Depreciation/ Amortization | 354.33 | 321.40 | -% | 345.57 | -% |
| Other Operating Expenses Total | 1,805.86 | 1,623.44 | -% | 1,727.49 | -% |
| Total Operating Expense | 6,369.50 | 5,774.12 | -% | 5,855.93 | -% |
| Operating Income | 1,210.65 | 633.01 | -% | 617.03 | -% |
| Net Income Before Taxes | 1,229.90 | 680.11 | -% | 730.06 | -% |
| Net Income | 908.75 | 491.26 | -% | 506.27 | -% |
| Diluted Normalized EPS | 17.05 | 8.38 | -% | 8.64 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST